The abstract is read at the publisher; the summary is JClub's.
C26 colorectal carcinoma induces greater cachexia than CT26 in syngeneic mice, causing body-weight loss and reduced skeletal muscle force output alongside higher interleukin-6 and muscle inflammation.
- Why it matters: CRC cachexia worsens prognosis and limits quality of life, yet parallel comparisons of the commonly used C26 versus CT26 models for muscle dysfunction and underlying signaling are limited.
- What they did: The study compared C26 and CT26 using in vitro co-culture with murine C2C12 myotubes and an in vivo syngeneic mouse model, measuring muscle mass, fat mass, force output, interleukin-6, inflammation, and protein turnover signaling.
- The result: Both cell lines caused significant atrophy in C2C12 myotubes and reduced muscle and fat mass in mice, but only C26 tumors reduced body weight and impaired force output, with C26 linked to greater muscle inflammation and distinct innate immune and protein turnover regulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.